DIN 02552671 — ETOPOSIDE INJECTION 20 MG
ETOPOSIDE INJECTION is a solution of Etoposide marketed by HIKMA CANADA LIMITED. The full Etoposide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552671
- Brand name
- ETOPOSIDE INJECTION
- Active ingredient
- Etoposide
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HIKMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Topoisomerase II inhibitor (antineoplastic agent, podophyllotoxin derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Etoposide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02080036 | ETOPOSIDE INJECTION | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02239961 | ETOPOSIDE INJECTION | 20 MG | LIQUID | FRESENIUS KABI CANADA LTD | DORMANT |
| 02422530 | ETOPOSIDE INJECTION, USP | 20 MG | SOLUTION | STRIDES PHARMA CANADA INC | DORMANT |
| 00616192 | VEPESID | 50 MG | CAPSULE | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |